Sustained hematologic and central nervous system remission with single-agent denileukin diftitox in refractory adult T-cell leukemia/lymphoma

Clinical Lymphoma and Myeloma

Volumn 7, Issue 7, 2007, Pages 472-474

  Evens, Andrew M ^a   Ziegler, Sheryl L ^a   Gupta, Rohit ^a   Augustyniak, Connie ^a   Gordon, Leo I ^a   Mehta, Jayesh ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Allogeneic stem cell transplantation; Human T cell lymphotrophic leukemia

Indexed keywords

ALPHA INTERFERON; ARSENIC TRIOXIDE; DENILEUKIN DIFTITOX; METHOTREXATE; ZIDOVUDINE;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANAMNESIS; ARTICLE; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE INTERVAL; FLOW CYTOMETRY; HUMAN; LABORATORY TEST; LEUKEMIC MENINGITIS; MALE; MULTIPLE CYCLE TREATMENT; PHYSICAL EXAMINATION; REMISSION; SYMPTOMATOLOGY; T CELL LEUKEMIA; T CELL LYMPHOMA;

EID: 34548735317     PISSN: 15579190     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLM.2007.n.030     Document Type: Article

References (11)

1. Nicot C. Current views in HTLV-I-associated adult T-cell leukemia/lymphoma. Am J Hematol 2005; 78:232-239.
2. Bazarbachi A, Ghez D, Lepelletier Y, et al. New therapeutic approaches for adult T-cell leukaemia. Lancet Oncol 2004; 5:664-672.
3. Gill PS, Harrington W, Kaplan MH, et al. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med 1995; 332:1744-1748.
4. Hermine O, Bouscary D, Gessain A, et al. Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. N Engl J Med 1995; 332:1749-1751.
5. Hermine O, Dombert H, Poupon J, et al. Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma. Hematol J 2004; 5:130-134.
6. Kami M, Hamaki T, Miyakoshi S, et al. Allogenic haematopoietic stem cell transplantation for the treatment of adult T-cell leukaemia/lymphoma. Br J Haematol 2005; 120:304-309.
7. Zhang M, Zhang Z, Goldman CK, et al. Combination therapy for adult T-cell leukemia-xenografted mice: flavopiridol and anti-CD255 monoclonal antibody. Blood 2005; 105:1231-1236.
8. Uchiyama T, Hori T, Tsudo M, et al. Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells. J Clin Invest 1985; 76:446-453.
9. Waldmann TA, Whote JD, Carrasquillo JA, et al. Radioimmunotherapy of interleukin-2Rα-expressing adult T-cell leukemia with yttrium-90-labeled anti-Tac. Blood 1995; 86:4063-4075.
10. Di Venuti G, Nawgiri R, Foss F. Denileukin diftitox and hyper-CVAD in the treatment of human T-cell lymphotrophic virus 1-associated acute T-cell leukemia/lymphoma. Clin Lymphoma 2003; 4:176-178.
11. Mone A, Puhalla S, Whitman S, et al. Durable hematological complete response and suppression of HTLV-I viral load following alemtuzumab in AZT/IFNα-refracrory adult T-cell leukemia. Blood 2005; 106:3380-3382.